|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.310 AUD | -1.70% |
|
+5.00% | -24.76% |
| 19/06 | EZZ Life Science Launches in the US; Shares Up 10% | MT |
| 19/06 | Ezz Life Science Launches In U.S. Market And Receives FDA Registrations | RE |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 271M | 2.71% | -11.02% | 1.1% | 0.89% | 13.93x | ||
| 2.96B | 27.16% | 32.27% | 21.78% | 14.29% | 0.11x | ||
| 2B | 12.35% | 19.15% | - | 33.43% | 1.73x | ||
| 1.33B | 10.46% | 18.64% | 11.24% | 8.18% | 0.98x | ||
| 937M | 9.55% | 12.04% | 5.81% | 4.44% | -0.99x | ||
| 444M | 10.55% | 14.89% | 8.47% | 5.82% | - | ||
| 510M | 7.07% | 15.7% | 14.61% | - | 2.56x | ||
| 577M | 7.72% | 7.77% | 13.27% | 6.09% | - | ||
| 4.99B | 5.09% | 10.28% | - | - | - | ||
| 41.48M | 31.16% | 36.15% | 5.36% | 5.06% | - | ||
| 340M | 12.98% | 22.4% | 14.46% | 9.39% | - | ||
| 76.12M | 22.36% | 22.77% | 8.16% | 7.5% | - | ||
| 428M | 17.24% | 27.17% | 25.82% | 15.68% | -0.85x | ||
| 855M | 4.92% | 7.76% | 8.17% | 6.09% | -1.66x | ||
| 281M | 7.62% | 10.42% | 20.63% | 10.57% | - | ||
| Average | 1.07B | 12.6% | 16.42% | 12.22% | 9.8% | 1.98x | |
| Weighted average by Cap. | 1.45B | 12.79% | 13.43% | 10.8% | 12.01% | 4.57x |
- Stock Market
- Equities
- EZZ Stock
- Sector EZZ Life Science Holdings Limited
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition